NEW YORK (GenomeWeb) – Belgian biopharmaceutical developer UCB announced today that it has acquired Durham, North Carolina-based Element Genomics for $30 million, which will include upfront and short-term success-based milestone payments.

A biotech spinout from Duke University, Element Genomics has developed several technologies to further understand genome structure and functions, such as CRISPR editing technology for genomic and epigenetic regulatory region analysis and modulation.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.